advertisement
Johnson M 36
Showing records 1 to 25 | Display only abstracts from Johnson M in IGR 21-194955 Surface Engineering of FLT4-Targeted Nanocarriers Enhances Cell-Softening Glaucoma Therapy
Vincent MP
ACS applied materials & interfaces 2021; 13: 32823-32836 (IGR: 22-2)
95022 Modeling the effects of glaucoma surgery on intraocular pressure
Farrar N; Yan DB
Experimental Eye Research 2021; 209: 108620 (IGR: 22-2)
94955 Surface Engineering of FLT4-Targeted Nanocarriers Enhances Cell-Softening Glaucoma Therapy
Stack T
ACS applied materials & interfaces 2021; 13: 32823-32836 (IGR: 22-2)
95022 Modeling the effects of glaucoma surgery on intraocular pressure
Johnson M
Experimental Eye Research 2021; 209: 108620 (IGR: 22-2)
94955 Surface Engineering of FLT4-Targeted Nanocarriers Enhances Cell-Softening Glaucoma Therapy
Vahabikashi A; Li G; Perkumas KM; Ren R; Gong H; Stamer WD; Johnson M; Scott EA
ACS applied materials & interfaces 2021; 13: 32823-32836 (IGR: 22-2)
90725 Targeted Delivery of Cell Softening Micelles to Schlemm's Canal Endothelial Cells for Treatment of Glaucoma
Stack T; Vincent M; Vahabikashi A; Li G; Perkumas KM; Stamer WD; Johnson M; Scott E
Small (Weinheim an der Bergstrasse, Germany) 2020; 16: e2004205 (IGR: 21-3)
84092 Economic Burden of Non-Infectious Inflammatory Eye Disease (NIIED) in a Commercially-Insured Population in the United States
Albini TA
Ocular Immunology and Inflammation 2020; 28: 164-174 (IGR: 21-1)
84685 Increased stiffness and flow resistance of the inner wall of Schlemm's canal in glaucomatous human eyes
Vahabikashi A; Gelman A
Proceedings of the National Academy of Sciences of the United States of America 2019; 0: (IGR: 21-1)
84092 Economic Burden of Non-Infectious Inflammatory Eye Disease (NIIED) in a Commercially-Insured Population in the United States
Rice JB; White AG
Ocular Immunology and Inflammation 2020; 28: 164-174 (IGR: 21-1)
84685 Increased stiffness and flow resistance of the inner wall of Schlemm's canal in glaucomatous human eyes
Dong B; Gong L
Proceedings of the National Academy of Sciences of the United States of America 2019; 0: (IGR: 21-1)
84092 Economic Burden of Non-Infectious Inflammatory Eye Disease (NIIED) in a Commercially-Insured Population in the United States
Johnson M
Ocular Immunology and Inflammation 2020; 28: 164-174 (IGR: 21-1)
84685 Increased stiffness and flow resistance of the inner wall of Schlemm's canal in glaucomatous human eyes
Cha EDK
Proceedings of the National Academy of Sciences of the United States of America 2019; 0: (IGR: 21-1)
84092 Economic Burden of Non-Infectious Inflammatory Eye Disease (NIIED) in a Commercially-Insured Population in the United States
Reiff J
Ocular Immunology and Inflammation 2020; 28: 164-174 (IGR: 21-1)
84685 Increased stiffness and flow resistance of the inner wall of Schlemm's canal in glaucomatous human eyes
Schimmel M
Proceedings of the National Academy of Sciences of the United States of America 2019; 0: (IGR: 21-1)
84092 Economic Burden of Non-Infectious Inflammatory Eye Disease (NIIED) in a Commercially-Insured Population in the United States
Lima AF; Bartels-Peculis L
Ocular Immunology and Inflammation 2020; 28: 164-174 (IGR: 21-1)
84685 Increased stiffness and flow resistance of the inner wall of Schlemm's canal in glaucomatous human eyes
Tamm ER; Perkumas K
Proceedings of the National Academy of Sciences of the United States of America 2019; 0: (IGR: 21-1)
84092 Economic Burden of Non-Infectious Inflammatory Eye Disease (NIIED) in a Commercially-Insured Population in the United States
Ciepielewska G; Nelson WW
Ocular Immunology and Inflammation 2020; 28: 164-174 (IGR: 21-1)
84685 Increased stiffness and flow resistance of the inner wall of Schlemm's canal in glaucomatous human eyes
Stamer WD; Sun C; Zhang HF; Gong H; Johnson M
Proceedings of the National Academy of Sciences of the United States of America 2019; 0: (IGR: 21-1)
78116 Rho Kinase Inhibitors as a Novel Treatment for Glaucoma and Ocular Hypertension
Tanna AP; Johnson M
Ophthalmology 2018; 125: 1741-1756 (IGR: 19-4)
76552 Modulation of Schlemm's canal endothelial cell stiffness via latrunculin loaded block copolymer micelles
Stack T; Vahabikashi A; Johnson M; Scott E
Journal of Biomedical Materials Research - Part A 2018; 106: 1771-1779 (IGR: 19-3)
60132 Finite element analysis of the pressure-induced deformation of Schlemm's canal endothelial cells
Vargas-Pinto R; Lai J; Gong H; Ethier CR; Johnson M
Biomechanics and modeling in mechanobiology 2015; 14: 851-863 (IGR: 16-4)
59134 Biomechanics of Schlemm's canal endothelium and intraocular pressure reduction
Stamer WD; Braakman ST; Zhou EH; Ethier CR; Fredberg JJ; Overby DR; Johnson M
Progress in Retinal and Eye Research 2015; 44: 86-98 (IGR: 16-3)
59082 Altered mechanobiology of Schlemm's canal endothelial cells in glaucoma
Overby DR; Zhou EH; Vargas-Pinto R; Pedrigi RM; Fuchshofer R; Braakman ST; Gupta R; Perkumas KM; Sherwood JM; Vahabikashi A; Dang Q; Kim JH; Ethier CR; Stamer WD; Fredberg JJ; Johnson M
Proceedings of the National Academy of Sciences of the United States of America 2014; 111: 13876-13881 (IGR: 16-3)
48805 Mechanical responsiveness of the endothelial cell of Schlemm's canal: scope, variability and its potential role in controlling aqueous humour outflow
Zhou EH; Krishnan R; Stamer WD; Perkumas KM; Rajendran K; Nabhan JF; Lu Q; Fredberg JJ; Johnson M
Journal of the Royal Society, Interface / the Royal Society 2012; 9: 1144-11455 (IGR: 14-1)
46877 Costs and effects of fixed combination therapies in open angle glaucoma
Wickstrom J; Centofanti M; Johnson M
Value in Health 2010; 13: 399-400 (IGR: 13-3)
